<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCDSA</journal-id><journal-title-group><journal-title>Journal of Cosmetics, Dermatological Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2161-4105</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jcdsa.2020.101004</article-id><article-id pub-id-type="publisher-id">JCDSA-99022</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Effect of a Cosmetic Use with 2% Isostearyl-L-Ascorbic Acid Gel for Postinflammatory Hyperpigmentation and Postinflammatory Erythema in Acne Vulgaris
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ichiro</surname><given-names>Kurokawa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Masako</surname><given-names>Watanabe</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kazuhito</surname><given-names>Hayashibe</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Dermatology, Meiwa Hospital, Nishinomiya, Hyogo, Japan</addr-line></aff><aff id="aff3"><addr-line>Hayashibe Skin Clinic, Sanda, Japan</addr-line></aff><aff id="aff2"><addr-line>Kobayashi Skin Clinic, Kobe, Japan</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>01</month><year>2020</year></pub-date><volume>10</volume><issue>01</issue><fpage>28</fpage><lpage>32</lpage><history><date date-type="received"><day>29,</day>	<month>February</month>	<year>2020</year></date><date date-type="rev-recd"><day>20,</day>	<month>March</month>	<year>2020</year>	</date><date date-type="accepted"><day>23,</day>	<month>March</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Postinflammatory hyperpigmentation (PIH) and postinflammatory erythema (PIE) in acne vulgaris are important and refractory complications for patients with acne vulgaris. To clarify the effects of 2% isostearyl-L-ascorbic acid (ISAA) against PIH and PIE in acne vulgaris, a clinical pilot study with topical 2% ISAA gel was performed in 25 acne patients with PIH and PIE. Topical ISAA gel was applied on the whole face with PIH and PIE in acne vulgaris twice a day for 3 months. Regarding PIH and PIE, investigator’s global improvement rating (IGIR) was evaluated in 7-point scales according to the reduced area of PIH and PIE before and after the study. Remarkable improvement in PIH was observed in 7 patients (28.0%) and in PIE in 12 (48%) of the 25 patients. No adverse reactions were observed during the treatment. Topical ISAA application can be an alternative, non-invasive available treatment for PIH and PIE in acne vulgaris.
 
</p></abstract><kwd-group><kwd>Acne</kwd><kwd> Vitamin C</kwd><kwd> Postinflammatory Hyperpigmentation</kwd><kwd> Postinflammatory Erythema</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Funding Acknowledgement</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></sec><sec id="s2"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest in preparing this article.</p></sec><sec id="s3"><title>Cite this paper</title><p>Kurokawa, I., Watanabe, M. and Hayashibe, K. (2020) Effect of a Cosmetic Use with 2% Isostearyl-L-Ascorbic Acid Gel for Postinflammatory Hyperpigmentation and Postinflammatory Erythema in Acne Vulgaris. Journal of Cosmetics, Dermatological Sciences and Applications, 10, 28-32. https://doi.org/10.4236/jcdsa.2020.101004</p></sec></body><back><ref-list><title>References</title><ref id="scirp.99022-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hayashi, N., Akamatsu, H., Iwatsuki, K., et al. (2018) Japanese Dermatological Association Guidelines: Guidelines for the Treatment of Acne Vulgaris 2017. The Journal of Dermatology, 45, 898-935. https://doi.org/10.1111/1346-8138.14355</mixed-citation></ref><ref id="scirp.99022-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kurokawa, I., Oiso, N. and Kawada, A. (2017) Adjuvant Alternative Treatment with Chemical Peeling and Subsequent Iontophoresis for Postinflammatory Hyperpigmentation, Erosion with Inflamed Red Papules and Non-Inflamed Atrophic Scars in Acne Vulgaris. The Journal of Dermatology, 44, 401-405. https://doi.org/10.1111/1346-8138.13634</mixed-citation></ref><ref id="scirp.99022-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Shibayama, H., Hisama, M., Matsuda, S. and Ohtsuki, M. (2008) Permeation and Metabolism of a Novel Ascorbic Acid Derivative, Disodium Isostearyl 2-L-Ascorbyl Phosphate, in Human Living Skin Equivalent Model. Skin Pharmacology and Physiology, 21, 235-248. https://doi.org/10.1159/000139128</mixed-citation></ref><ref id="scirp.99022-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Matsuda, S., Shibayama, H., Hisama, M., Ohtsuki, M. and Iwaki, M. (2008) Inhibitory Effects of a Novel Ascorbic Derivative, Disodium Isostearyl 2-O-L-Ascorbyl Phosphate on Melanogenesis. Chemical and Pharmaceutical Bulletin, 56, 292-297. https://doi.org/10.1248/cpb.56.292</mixed-citation></ref><ref id="scirp.99022-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mohammed, B.M., Fisher, B.J., Kraskauskas, D., et al. (2016) Vitamin C Promotes Wound Healing through Novel Pleiotropic Mechanisms. International Wound Journal., 13, 572-584. https://doi.org/10.1111/iwj.12484</mixed-citation></ref><ref id="scirp.99022-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Inui, S. and Itami, S. (2007) Perifollicular Pigmentation Is the First Target for Topical Vitamin C Derivative Ascorbyl 2-Phosphate 6-Palmitate (APPS): Randomized, Single-Blinded, Placebo-Controlled Study. The Journal of Dermatology, 34, 221-223. https://doi.org/10.1111/j.1346-8138.2007.00256.x</mixed-citation></ref></ref-list></back></article>